Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH), 51567 [2015-20999]

Download as PDF Federal Register / Vol. 80, No. 164 / Tuesday, August 25, 2015 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–21001 Filed 8–24–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) asabaliauskas on DSK5VPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Time and Date: 8:30 a.m.–3:00 p.m., EDT, September 22, 2015. Place: Patriots Plaza I, 395 E Street SW., Room 9000, Washington, DC 20201. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 33 people. The meeting is also open to the public via webcast. If you wish to attend in person or by webcast, please see the NIOSH Web site to register (https://www.cdc.gov/niosh/bsc/) or call (404–498–2539) at least five business days in advance of the meeting. Teleconference is available toll-free; please dial (888) 397–9578, Participant Pass Code 63257516. Members of the public who wish to address the BSC, NIOSH are requested to contact the Executive Secretary for scheduling purposes (see contact information below). Alternatively, written comments to the BSC may be submitted via an on-line form at the following Web site: https:// www.cdc.gov/niosh/bsc/contact.html. Purpose: The Secretary, the Assistant Secretary for Health, and by delegation the Director, Centers for Disease Control and Prevention, are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors provides guidance to the Director, National Institute for Occupational Safety and Health on research and prevention programs. Specifically, the Board provides guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings and disseminating results. The Board evaluates the degree to which the activities of the National Institute for Occupational Safety and Health: (1) Conform to appropriate scientific standards, (2) address current, relevant needs, and (3) produce intended results. Matters for Discussion: NIOSH Director’s update, Structuring Labor-Management VerDate Sep<11>2014 17:10 Aug 24, 2015 Jkt 235001 Participation in Research, Systematic Review (Grading Evidence and Recommendations), Occupational Exposure Banding, and an Update from the NIOSH Research Translation Office. Agenda items are subject to change as priorities dictate. An agenda is also posted on the NIOSH Web site (https://www.cdc.gov/ niosh/bsc/). Contact Person for More Information: John Decker, Executive Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS–E20, Atlanta, GA 30329–4018, telephone (404) 498–2500, fax (404) 498–2526. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–20999 Filed 8–24–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Advisory Board on Radiation and Worker Health: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Board on Radiation and Worker Health, Department of Health and Human Services, has been renewed for a 2-year period through August 3, 2017. For information, contact Mr. Theodore Katz, Designated Federal Officer, Advisory Board on Radiation and Worker Health, Department of Health and Human Services, 1600 Clifton Road, M/S E20, Atlanta, Georgia 30341, telephone 404/498–2533, or fax 404/498–2570. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–21000 Filed 8–24–15; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 51567 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–2048] Medical Device Epidemiology Network Registry Task Force Report; Availability, Web Site Location and Request for Comments AGENCY: Food and Drug Administration, HHS. ACTION: Notice; request for comments. The Food and Drug Administration (FDA) is announcing the availability of the report and Web site location where the Agency has posted the report entitled ‘‘Recommendations for a National Medical Device Evaluation System: Strategically Coordinated Registry Networks to Bridge the Clinical Care and Research,’’ developed by the Medical Device Epidemiology Network’s Medical Device Registry Task Force. In addition, FDA has established a docket where stakeholders may provide comments. DATES: Submit either electronic or written comments by October 26, 2015. ADDRESSES: Submit electronic comments on this document to https:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Danica Marinac-Dabic, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 4110, Silver Spring, MD 20993–0002, 301– 796–6689, email: Danica.marinacdabic@fda.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background FDA’s Center for Devices and Radiological Health is responsible for protecting the public health by assuring the safety and effectiveness of medical devices and radiation-emitting products. A key part of this mission is to monitor medical devices and radiological products for continued safety and effectiveness after they are in use and to help the public get the accurate, science-based information they need to improve their health. In September 2012, the FDA published a report, ‘‘Strengthening Our National System for Medical Device Postmarket Surveillance,’’ that proposed E:\FR\FM\25AUN1.SGM 25AUN1

Agencies

[Federal Register Volume 80, Number 164 (Tuesday, August 25, 2015)]
[Notices]
[Page 51567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20999]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

    Time and Date: 8:30 a.m.-3:00 p.m., EDT, September 22, 2015.
    Place: Patriots Plaza I, 395 E Street SW., Room 9000, 
Washington, DC 20201.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 33 people. The meeting 
is also open to the public via webcast. If you wish to attend in 
person or by webcast, please see the NIOSH Web site to register 
(https://www.cdc.gov/niosh/bsc/) or call (404-498-2539) at least five 
business days in advance of the meeting. Teleconference is available 
toll-free; please dial (888) 397-9578, Participant Pass Code 
63257516. Members of the public who wish to address the BSC, NIOSH 
are requested to contact the Executive Secretary for scheduling 
purposes (see contact information below). Alternatively, written 
comments to the BSC may be submitted via an on-line form at the 
following Web site: https://www.cdc.gov/niosh/bsc/contact.html.
    Purpose: The Secretary, the Assistant Secretary for Health, and 
by delegation the Director, Centers for Disease Control and 
Prevention, are authorized under Sections 301 and 308 of the Public 
Health Service Act to conduct directly or by grants or contracts, 
research, experiments, and demonstrations relating to occupational 
safety and health and to mine health. The Board of Scientific 
Counselors provides guidance to the Director, National Institute for 
Occupational Safety and Health on research and prevention programs. 
Specifically, the Board provides guidance on the Institute's 
research activities related to developing and evaluating hypotheses, 
systematically documenting findings and disseminating results. The 
Board evaluates the degree to which the activities of the National 
Institute for Occupational Safety and Health: (1) Conform to 
appropriate scientific standards, (2) address current, relevant 
needs, and (3) produce intended results.
    Matters for Discussion: NIOSH Director's update, Structuring 
Labor-Management Participation in Research, Systematic Review 
(Grading Evidence and Recommendations), Occupational Exposure 
Banding, and an Update from the NIOSH Research Translation Office.
    Agenda items are subject to change as priorities dictate. An 
agenda is also posted on the NIOSH Web site (https://www.cdc.gov/niosh/bsc/).
    Contact Person for More Information: John Decker, Executive 
Secretary, BSC, NIOSH, CDC, 1600 Clifton Road NE., MS-E20, Atlanta, 
GA 30329-4018, telephone (404) 498-2500, fax (404) 498-2526.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-20999 Filed 8-24-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.